Shares of Bio-Rad Laboratories, Inc. (NYSE: BIO - Get Free Report) have been given a consensus rating of "Hold" by the six ratings firms that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and three have given a buy

Exchange Traded Concepts LLC lifted its position in Bio-Rad Laboratories, Inc. (NYSE: BIO) by 54.9% in the undefined quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 21,580 shares of the medical research company's stock after acquiring an additional 7,648 shares during the period. Exchange Traded Concepts

Texas Permanent School Fund Corp reduced its position in shares of Bio-Rad Laboratories, Inc. (NYSE: BIO) by 17.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,556 shares of the medical research company's stock after selling 2,066 shares during the

Federated Hermes Inc. lowered its stake in shares of Bio-Rad Laboratories, Inc. (NYSE: BIO) by 9.4% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 127,058 shares of the medical research company's stock after selling 13,192 shares during the quarter. Federated Hermes Inc.

Ariel Investments LLC boosted its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE: BIO) by 13.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 818,624 shares of the medical research company's stock after acquiring an additional 93,964 shares during the

Fisher Asset Management LLC lowered its position in shares of Bio-Rad Laboratories, Inc. (NYSE: BIO) by 4.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 137,742 shares of the medical research company's stock after selling 5,884 shares during the quarter. Fisher Asset

JUPITER, Fla. and WAGENINGEN, Netherlands, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Dyadic Applied BioSolutions (“Dyadic”), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes across life science, food & nutrition, and bioindustrial markets, and BRIG BIO (official legal entity The Protein Collective B.V.

Artisan Partners Limited Partnership cut its holdings in Bio-Rad Laboratories, Inc. (NYSE: BIO) by 1.4% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 118,198 shares of the medical research company's stock after selling 1,670 shares during the period. Artisan

Digital Identity & Biometric Access Management Provider BIO-key (Nasdaq:BKYI) Reports Q3 Results; Enhanced Post Quarter Balance Sheet Supports 2026 Growth.

BIO-key (BKYI) Partners with VaporVM to Expand Reach of Advanced Identity & Access Management and Biometric Cybersecurity Solutions in Middle East, Africa.